Sumitomo Mitsui Trust Group’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$23.8M Sell
1,832,467
-93,617
-5% -$1.22M 0.01% 617
2025
Q1
$20.4M Sell
1,926,084
-138,966
-7% -$1.47M 0.01% 637
2024
Q4
$35M Sell
2,065,050
-210,665
-9% -$3.57M 0.02% 541
2024
Q3
$52.8M Buy
2,275,715
+712,650
+46% +$16.5M 0.04% 436
2024
Q2
$38.1M Buy
1,563,065
+286,546
+22% +$6.98M 0.03% 498
2024
Q1
$43.1M Sell
1,276,519
-44,133
-3% -$1.49M 0.03% 534
2023
Q4
$41.6M Sell
1,320,652
-67,922
-5% -$2.14M 0.03% 528
2023
Q3
$35.5M Sell
1,388,574
-16,358
-1% -$418K 0.03% 551
2023
Q2
$40.3M Sell
1,404,932
-16,393
-1% -$470K 0.03% 533
2023
Q1
$34.1M Sell
1,421,325
-27,735
-2% -$665K 0.03% 597
2022
Q4
$24.6M Sell
1,449,060
-10,355
-0.7% -$176K 0.02% 667
2022
Q3
$21.6M Buy
1,459,415
+23,221
+2% +$344K 0.02% 688
2022
Q2
$22.6M Buy
1,436,194
+34,116
+2% +$537K 0.02% 696
2022
Q1
$37.8M Buy
1,402,078
+44,606
+3% +$1.2M 0.03% 612
2021
Q4
$50.2M Sell
1,357,472
-1,060
-0.1% -$39.2K 0.03% 534
2021
Q3
$64.9M Buy
1,358,532
+143,631
+12% +$6.86M 0.04% 465
2021
Q2
$41.1M Buy
1,214,901
+899,089
+285% +$30.4M 0.02% 598
2021
Q1
$13M Buy
315,812
+181,208
+135% +$7.48M 0.01% 756
2020
Q4
$5.84M Buy
134,604
+3,434
+3% +$149K ﹤0.01% 826
2020
Q3
$5.63M Sell
131,170
-15,182
-10% -$651K ﹤0.01% 812
2020
Q2
$6.84M Sell
146,352
-108,714
-43% -$5.08M ﹤0.01% 779
2020
Q1
$3.47M Sell
255,066
-25,482
-9% -$346K ﹤0.01% 816
2019
Q4
$3.05M Sell
280,548
-17,982
-6% -$195K ﹤0.01% 857
2019
Q3
$3.07M Buy
298,530
+168,556
+130% +$1.73M ﹤0.01% 833
2019
Q2
$1.23M Buy
+129,974
New +$1.23M ﹤0.01% 880